- Clinical Interests
- Memory disorders
- Olfactory disorders
- Medical Education
- MD, Harvard Medical School
- PhD, Harvard University
- Residency, Brigham and Women's Hospital|Residency, Massachusetts General Hospital
- Fellowship, Neurological Institute of New York
- Board Certifications
- Boston: Massachusetts General Hospital
- Patient Gateway
- Yes, learn more
- Insurances Accepted
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Medicare - ACD
- Neighborhood Health Plan - ACD
- Neighborhood Health Plan - PBO
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Senior Whole Health
- Tufts Health Plan
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
- Patient Age Group
- Research Summary
The goal of the research in the Albers lab is to elucidate the pathogenic actions and physiological functions of genes implicated in neurodegenerative disease.
Read more about the Albers Lab.
A non-invasive protocol developed by Massachusetts General Hospital investigators that tests the ability to recognize, remember and distinguish between odors was able to identify older individuals who &ndash; according to genetic, imaging and more detailed memory tests &ndash; were at increased risk of Alzheimer&rsquo;s disease.
Mark Albers, MD, PhD, of the Department of Neurology, was named the first incumbent of the Frank Wilkens, Jr. and Family Endowed Chair in Alzheimer&rsquo;s Disease Research.
15 Parkman Street
Boston, MA 02114-3117